ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options
Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate – whether as a standalone cloud application or as an integrated extension of ZEISS FORUM – enabling secure data sharing,...
ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
JENA, Germany, March 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has received National Medical Products Administration (NMPA)...
ZEISS VISUMAX 800 with SMILE pro software receives approval in China
Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow JENA, Germany and SHANGHAI, Feb. 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today that the...
ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with treatment for myopia, hyperopia, and mixed astigmatism. DUBLIN, Calif. and JENA, Germany, Jan. 13, 2025 /PRNewswire/ -- ZEISS...